Provider resources

Know what you can offer, state by state, with sources.

A plain-English reference for clinics adding peptides: thirty-nine compound lights, FDA and board sources for every state, and the questions clinicians ask first. Free to read, with a primary source behind every answer.

Can I prescribe X?

One light and one sentence for 39 compounds clinics ask about.

What does my state say?

The pharmacy board for every state and D.C., plus the FDA pages that set the baseline.

Common questions

The questions clinicians ask before adding peptides, answered in a sentence or two.

Read the answers

Three lights. One sentence each.

Every compound gets one light based on FDA status and what a licensed pharmacy can put in writing today. Open a compound for the prescribe, compound, and sell detail.

See all 39 compounds
  • Ready to prescribe9 compounds

    An FDA-approved finished drug. A licensed clinician prescribes it and a pharmacy fills it the way it fills any other specialty injectable.

  • Possible with conditions18 compounds

    Not an approved finished drug, or compounding is contested. It needs a pharmacy that will put its authority in writing and consent language that says the product is compounded.

  • Don't touch12 compounds

    Investigational, barred from compounding, or only sold by research-use-only vendors. Keep it off the menu and train the front desk on a one-line refusal.

Can a med spa legally offer peptides?

Only through a licensed prescriber and a licensed pharmacy, for compounds that pharmacy can lawfully supply, under state scope-of-practice and medical-director rules. Full answer and sources

Did the July 2026 PCAC meeting make BPC-157 and TB-500 legal to compound?

No. PCAC advises FDA and its recommendations are non-binding. FDA's own meeting materials proposed not listing either peptide, FDA has posted no decision, and neither is in any 503A category. Full answer and sources

If a peptide is on the 503A Category 1 list, can we compound it tomorrow?

Not automatically. Category 1 means FDA is evaluating the bulk under the interim policy; it is not approval of a finished drug, and pharmacies still decide what they will fill. Full answer and sources

Are compounded GLP-1s the same as Wegovy or Zepbound?

No. Branded products are approved finished drugs; compounded GLP-1s are unapproved preparations with FDA-published concerns about salt forms, dosing errors, and quality. Full answer and sources

Can we put NAD+ IV drips on the wellness menu?

Only if a licensed pharmacy will compound under Category 1 conditions and you document a clinical rationale. Wellness marketing is not a federal green light. Full answer and sources

A patient wants Melanotan II for tanning. Can we help?

No. Melanotan II is not FDA-approved, and FDA has warned about unapproved Melanotan tanning products. Hard clinical no. Full answer and sources

Is a research-use-only peptide seller okay if patients sign a waiver?

No. A patient waiver does not turn a research-use-only seller into a pharmacy. Full answer and sources

Where do state rules fit if FDA is federal?

Federal compounding pages set the baseline. State pharmacy boards decide licensing, nonresident shipping, and local enforcement; medical boards own supervision and med-spa scope. Full answer and sources

Read in order

18 short guides and tools, grouped the way a clinic actually works through them. Track 4 is for dentists, periodontists, and oral surgeons.

Free download

Provider Peptide Field Guide

Six pages your medical director, front desk, and pharmacy partner can all read. Unlocking also opens the citations and full detail across this hub.

  • One-page map of prescribe, compound, and sell
  • All 39 compounds with plain-language status
  • 503A vs 503B, and how to read FDA and your board
  • Ten clinic questions with citations, plus a launch checklist

Work email. Takes ten seconds.

About this hub

Is this legal advice?
No. This hub is an educational reference for clinic operators. Prescribing, compounding, and consent decisions belong with licensed clinicians, pharmacists, and your counsel. PeptIQ.io does not sell, source, or dispense peptides.
Who is this for?
Physicians, NPs, PAs, med-spa medical directors, chiropractors with a prescriber, sports-medicine and primary-care clinics that are peptide-curious but unsure what they can prescribe, compound, or sell.
What is free and what needs a work email?
Free: the light for every compound, topic filters, search, every question with a short answer, and the board link for every state. A work email unlocks the prescribe, compound, and sell detail with citations, full answers, and the Provider Peptide Field Guide PDF.
How many compounds and sources are covered?
The status tool covers thirty-nine educational compound rows (approved GLP-1s and specialty peptides through Category 1 asks and hard nos like Melanotan II and GHRPs). Sources include the federal FDA baseline, featured guidance for high-traffic states, and pharmacy board links for all 50 states plus D.C.

Ready to run a peptide program with less guesswork?

The PeptIQ.io provider console assigns protocols, keeps patients logging between visits, and shows adherence per patient. A 20-minute walkthrough is enough to see whether it fits your clinic.

Educational reference only, not legal, medical, or regulatory advice. PeptIQ.io does not sell, source, or dispense peptides. Your counsel, your pharmacy, and your state boards decide what applies to your clinic. Verify every source before you rely on it.